Dr. Agarwal's Eye Hospital Limited (BOM:526783)

BOM:526783 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	25,971	22,712	19,046	14,586	4,302	3,435
Market Cap Growth	22.74%	19.25%	30.58%	239.06%	25.22%	133.46%
Enterprise Value	28,274	25,133	21,948	16,548	5,948	3,781
Last Close Price	5373.85	4699.55	4047.03	3095.84	911.08	725.44

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	33.85	32.40	34.85	31.46	11.65	14.26
PS Ratio	5.23	4.82	4.80	4.57	1.61	1.71
PB Ratio	7.50	6.56	9.09	9.28	3.80	4.39
P/TBV Ratio	8.15	7.13	10.49	9.33	3.83	4.49
P/FCF Ratio	55.55	48.58	-	79.06	-	34.53
P/OCF Ratio	17.89	15.65	20.36	16.25	6.18	6.06

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	5.69	5.34	5.53	5.18	2.22	1.88
EV/EBITDA Ratio	18.10	19.92	21.52	21.23	9.24	7.73
EV/EBIT Ratio	26.96	25.22	27.71	25.58	10.85	10.14
EV/FCF Ratio	60.48	53.76	-	89.69	-	38.00

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.94	0.94	1.59	1.71	2.05	2.48
Debt / EBITDA Ratio	2.09	2.25	2.81	2.94	3.11	3.38
Debt / FCF Ratio	-	6.98	-	14.53	-	19.44
Net Debt / Equity Ratio	0.67	0.67	1.48	1.50	1.81	2.12
Net Debt / EBITDA Ratio	1.47	1.83	3.04	3.02	3.19	3.38
Net Debt / FCF Ratio	-	4.93	-33.36	12.75	-284.85	16.62
Asset Turnover	-	0.68	0.72	0.72	0.76	0.86
Inventory Turnover	-	18.86	19.52	23.72	26.88	11.87
Quick Ratio	-	1.04	0.43	0.57	0.69	0.74
Current Ratio	-	1.23	0.63	0.74	0.85	0.94
Return on Equity (ROE)	-	25.22%	29.80%	34.28%	38.56%	36.29%
Return on Assets (ROA)	-	9.03%	8.93%	9.13%	9.74%	9.93%
Return on Invested Capital (ROIC)	13.67%	13.61%	13.42%	13.55%	14.58%	16.16%
Return on Capital Employed (ROCE)	-	15.20%	15.00%	15.60%	16.40%	14.30%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.93%	3.09%	2.87%	3.18%	8.58%	7.02%
FCF Yield	1.80%	2.06%	-0.49%	1.26%	-0.17%	2.90%
Dividend Yield	0.13%	0.15%	0.15%	0.16%	0.33%	0.41%
Payout Ratio	-	4.41%	4.30%	5.56%	3.82%	0.08%
Buyback Yield / Dilution	-2.15%	-1.45%	-	-	-	-
Total Shareholder Return	-2.02%	-1.30%	0.15%	0.16%	0.33%	0.41%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error